These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32304215)

  • 41. Adaptive B Cell Responses to Influenza Virus Infection in the Lung.
    Takahashi Y; Onodera T; Adachi Y; Ato M
    Viral Immunol; 2017; 30(6):431-437. PubMed ID: 28661720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
    Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigenic commonality and divergence of hemagglutinin-esterase-fusion protein among influenza D virus lineages revealed using epitope mapping.
    Katayama M; Murakami S; Ishida H; Matsugo H; Sekine W; Ohira K; Takenaka-Uema A; Horimoto T
    J Virol; 2024 Mar; 98(3):e0190823. PubMed ID: 38345383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influenza vaccine: progress in a vaccine that elicits a broad immune response.
    Isakova-Sivak I; Stepanova E; Mezhenskaya D; Matyushenko V; Prokopenko P; Sychev I; Wong PF; Rudenko L
    Expert Rev Vaccines; 2021 Sep; 20(9):1097-1112. PubMed ID: 34348561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope.
    Bajic G; Maron MJ; Adachi Y; Onodera T; McCarthy KR; McGee CE; Sempowski GD; Takahashi Y; Kelsoe G; Kuraoka M; Schmidt AG
    Cell Host Microbe; 2019 Jun; 25(6):827-835.e6. PubMed ID: 31104946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A recombinant protein containing influenza viral conserved epitopes and superantigen induces broad-spectrum protection.
    Li Y; Xu M; Li Y; Gu W; Halimu G; Li Y; Zhang Z; Zhou L; Liao H; Yao S; Zhang H; Zhang C
    Elife; 2021 Nov; 10():. PubMed ID: 34783655
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans.
    Andrews SF; Cominsky LY; Shimberg GD; Gillespie RA; Gorman J; Raab JE; Brand J; Creanga A; Gajjala SR; Narpala S; Cheung CSF; Harris DR; Zhou T; Gordon I; Holman L; Mendoza F; Houser KV; Chen GL; Mascola JR; Graham BS; Kwong PD; Widge A; Dropulic LK; Ledgerwood JE; Kanekiyo M; McDermott AB
    Sci Transl Med; 2023 Apr; 15(692):eade4976. PubMed ID: 37075126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance.
    Chen YQ; Lan LY; Huang M; Henry C; Wilson PC
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epitope-targeting platform for broadly protective influenza vaccines.
    Zeigler DF; Gage E; Clegg CH
    PLoS One; 2021; 16(5):e0252170. PubMed ID: 34043704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.
    Carter DM; Darby CA; Lefoley BC; Crevar CJ; Alefantis T; Oomen R; Anderson SF; Strugnell T; Cortés-Garcia G; Vogel TU; Parrington M; Kleanthous H; Ross TM
    J Virol; 2016 May; 90(9):4720-4734. PubMed ID: 26912624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targets.
    McCutcheon KM; Gray J; Chen NY; Liu K; Park M; Ellsworth S; Tripp RA; Tompkins SM; Johnson SK; Samet S; Pereira L; Kauvar LM
    MAbs; 2014; 6(2):460-73. PubMed ID: 24492306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cells.
    Miyauchi K; Adachi Y; Tonouchi K; Yajima T; Harada Y; Fukuyama H; Deno S; Iwakura Y; Yoshimura A; Hasegawa H; Yugi K; Fujii SI; Ohara O; Takahashi Y; Kubo M
    Nat Commun; 2021 Jun; 12(1):3789. PubMed ID: 34145279
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.
    Quiñones-Parra SM; Clemens EB; Wang Z; Croom HA; Kedzierski L; McVernon J; Vijaykrishna D; Kedzierska K
    J Virol; 2016 Aug; 90(15):6936-6947. PubMed ID: 27226365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exposure of an occluded hemagglutinin epitope drives selection of a class of cross-protective influenza antibodies.
    Adachi Y; Tonouchi K; Nithichanon A; Kuraoka M; Watanabe A; Shinnakasu R; Asanuma H; Ainai A; Ohmi Y; Yamamoto T; Ishii KJ; Hasegawa H; Takeyama H; Lertmemongkolchai G; Kurosaki T; Ato M; Kelsoe G; Takahashi Y
    Nat Commun; 2019 Aug; 10(1):3883. PubMed ID: 31462639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A broadly neutralizing human monoclonal antibody directed against a novel conserved epitope on the influenza virus H3 hemagglutinin globular head.
    Benjamin E; Wang W; McAuliffe JM; Palmer-Hill FJ; Kallewaard NL; Chen Z; Suzich JA; Blair WS; Jin H; Zhu Q
    J Virol; 2014 Jun; 88(12):6743-50. PubMed ID: 24696468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stereotyped B-cell response that counteracts antigenic variation of influenza viruses.
    Tonouchi K; Adachi Y; Moriyama S; Sano K; Tabata K; Ide K; Takeyama H; Suzuki T; Takahashi Y
    Int Immunol; 2020 Sep; 32(9):613-621. PubMed ID: 32504541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.
    Wu NC; Wilson IA
    J Mol Biol; 2017 Aug; 429(17):2694-2709. PubMed ID: 28648617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD4+ follicular regulatory T cells optimize the influenza virus-specific B cell response.
    Lu Y; Jiang R; Freyn AW; Wang J; Strohmeier S; Lederer K; Locci M; Zhao H; Angeletti D; O'Connor KC; Kleinstein SH; Nachbagauer R; Craft J
    J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33326020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial.
    van Doorn E; Pleguezuelos O; Liu H; Fernandez A; Bannister R; Stoloff G; Oftung F; Norley S; Huckriede A; Frijlink HW; Hak E
    BMC Infect Dis; 2017 Apr; 17(1):241. PubMed ID: 28376743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
    Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
    Front Immunol; 2019; 10():756. PubMed ID: 31105689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.